Long-term complications after hematopoietic cell transplantation
Hematology/Oncology and Stem Cell Therapy · 2017-10 · 10 (4) · 220-227
DOI: 10.1016/j.hemonc.2017.05.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematology/Oncology and Stem Cell Therapy, 2017-10. Verfasst von Navneet S Majhail. Beteiligte Einrichtung: Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH, USA. Electronic address: majhain@ccf.org. Hauptthemen laut MEDLINE: Mortality, Quality of Life, Survivors. Die Arbeit wurde bisher 191-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT) survivors continues to increase. Among patients whose disease remains in remission for the first 2— 5 years after transplantation, it is estimated that approximately 80–90% will be alive over the subsequent 10 years. However, the relative mortality rates of such patients continue to remain higher than those of their general population peers, with late complications contributing to significant long-term morbidity and mortality. Late effects in HCT survivors include secondary cancers, organ specific complications, late infections, quality of life impairments, psychosocial issues, sexual and fertility concerns, financial toxicity, and issues around return to work/school. A patient-centric and multidisciplinary approach to HCT survivorship care with collaborative and coordinated care from transplant centers and community healthcare providers is necessary to ensure their long-term health. Lifelong follow-up of HCT survivors is recommended, with established guidelines serving as the template for providing screening and preventive care based on patient-specific exposures. This review discussed common late complications, models for care delivery, and gaps and priorities for future research in the field of HCT survivorship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH, USA. Electronic address: majhain@ccf.org.
Förderung
- NCI NIH HHS
Zitieren
APA
Majhail, N. S. (2017). Long-term complications after hematopoietic cell transplantation. Hematology/Oncology and Stem Cell Therapy, 10(4), 220-227. https://doi.org/10.1016/j.hemonc.2017.05.009
Vancouver
Majhail NS. Long-term complications after hematopoietic cell transplantation. Hematology/Oncology and Stem Cell Therapy. 2017;10(4):220-227. doi:10.1016/j.hemonc.2017.05.009
BibTeX
@article{Majhail2017,
author = {Majhail, Navneet S},
title = {Long-term complications after hematopoietic cell transplantation},
journal = {Hematology/Oncology and Stem Cell Therapy},
year = {2017},
volume = {10},
number = {4},
pages = {220--227},
doi = {10.1016/j.hemonc.2017.05.009}
}
EUVIMED